Stock Ratings / Health Care / LFST / earnings

OPCH (75) HIMS (63) CHE (84) AVAH (65) ⌘ Pro Terminal →

LifeStance Health Group Inc. (LFST) Next Earnings Date & Expected ±7.2% Move

$13.64 +1.83% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.66

LifeStance Health Group Inc. (LFST) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $5.21B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on LFST Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is LFST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-01, LifeStance Health Group Inc. (NASDAQ: LFST) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $13.64 (+1.83% 1D, market cap $5.21B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, LFST ranks #249 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does LFST compare to OPCH and HIMS in the Health Care sector?

▼

Within the Health Care sector (Medical/Nursing Services), LFST carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of 1.2%. By comparison, OPCH (Option Care Health Inc.) holds a B grade (75/100 RQD, P/E 23.0x, ROIC 11.9%, cap $4.77B) and HIMS (Hims & Hers Health Inc.) posts a C grade (63/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.92B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for LFST?

▼

Per LFST's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001845257), LifeStance Health Group Inc. generated $1.42B in revenue (+13.9% YoY), $9.7M in net income, and $110.0M in free cash flow against $2.20B in total assets and $265.9M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $13.66 (+0.14%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 7.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 57/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.2% avg 90D alpha vs SPY • 52.2% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE-0.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFST)Realized 20D OHLCV Swing Band: ±7.2%

Deterministic 5-Pillar Attribution (57/100 Composite)

🔍 WHY LFST SCORES 57/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (32% of score)

Altman Z-Score 4.84 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (18% of score)

SEC XBRL FY 2025 (10-K): 7.7% FCF Margin ($110.0M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$12.42-5.5% Next Q

Q2 (-2Q)

Grade C-$11.74+10.1% Next Q

Q3 (-1Q)

Grade C-$12.93+5.5% Next Q

Current

Grade D+$13.64-0.2% Hist 90D α

Trajectory: D (49) → D+ (57)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the LFST Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 57/100 (D+) score, LFST faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.48) or 200D SMA ($9.34) invalidates the momentum regime and cuts Target Base ($13.58) toward Bear Floor ($10.59).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $LFST• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “LFST Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 57%NO 43%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±7.2% Swing Band

±$0.98 Expected Swing

MODEL EARNINGS SETUP GAUGE

LFST Quantitative Pre-Earnings Setup: 57/100

Trailing EPS: $4.25 • YoY Revenue Growth: 13.9%

Model Bullish Setup (57/100)Model Risk Weight (43/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$1.42B	$9.7M	$110.0M	52%
FY 2024	2024-12-31	$1.25B	-$57.4M	$85.7M	52%
FY 2023	2023-12-31	$1.06B	-$186.3M	-$16.9M	52%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LFST)

✓Walkthrough of LFST's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

LFST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +80.18%📐 HORIZONTAL RANGE

2026-10-30O $13.64H $13.76L $13.27C $13.64VOL 2.30M

RES: $14.88SUP: $11.14SMA50: $12.48SMA200: $9.34

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

LFST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 LFST Butterfly Map → + Track LFST →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +13.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on LFST today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for LFST. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for LFST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFST)

Health Care Rank #249 of 1016 ⚔️ OPCH vs LFST Full Matrix →

1. Head-to-Head Health Care Peer Comparison (LFST vs. OPCH, HIMS, CHE, AVAH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, LifeStance Health Group Inc. (LFST) ranks #249 by composite RQD confidence (57/100, grade D+) and #165 by equity capitalization ($5.21B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while CHE leads on capital efficiency and profitability with 23.4% ROIC and 32.5% gross margin. CHE currently holds the highest overall quantitative score in the immediate peer group at 84/100 (A-) compared with LFST at 57/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
LFST ACTIVE LifeStance Health Group Inc.	D+	57/100	—	—	1.2%	+1.83%	$5.21B	Benchmark Subject
OPCH Option Care Health Inc.	B	75/100	23.0x	19.3%	11.9%	+1.79%	$4.77B	/opch-vs-lfst →
HIMS Hims & Hers Health Inc.	C	63/100	53.9x	73.8%	8.4%	+1.19%	$6.92B	/hims-vs-lfst →
CHE Chemed Corp	A-	84/100	—	32.5%	23.4%	+1.61%	$7.08B	/che-vs-lfst →
AVAH Aveanna Healthcare Holdings Inc.	C	65/100	—	33.3%	15.7%	+1.53%	$2.89B	/avah-vs-lfst →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001845257

In its most recent audited fiscal period (FY2025, filed 2025-12-31), LifeStance Health Group Inc. (LFST) reported GAAP revenue of $1.42B (+13.9% vs. FY2024 revenue of $1.25B , and +34.9% cumulative change since FY2023) , GAAP net income of $9.7M, operating cash flow of $146.2M, and free cash flow of $110.0M (+28.4% YoY). On the balance sheet, LFST closed FY2025 with $2.20B in total assets against $265.9M in total debt (Altman Z-Score: 4.84, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.42B	$9.7M	$146.2M	$110.0M	$2.20B	$265.9M
FY2024 (FY)	2024-12-31	$1.25B	-$57.4M	$107.3M	$85.7M	$2.12B	$279.8M
FY2023 (FY)	2023-12-31	$1.06B	-$186.3M	-$16.9M	-$16.9M	—	—

3. LFST Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is LFST stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does LFST compare to OPCH and HIMS in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for LFST?

Where is LFST trading relative to its 50-day, 200-day, and 52-week technical levels?

LFST last traded at $13.64 (+1.83% on volume of 2,470,474 shares), positioning the stock +9.29% above its 50-day simple moving average ($12.48) and +46.04% above its 200-day simple moving average ($9.34). Across its 52-week range of $4.77 to $13.76, LFST sits at the 98.7% percentile with a 14-day RSI of 64.8 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.2% ($12.66 to $14.62).

LFST Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is LFST's next earnings date?

Based on SEC filing cadence, LifeStance Health Group Inc. (LFST)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is LFST stock expected to move on earnings?

Volatility modeling currently projects a ±7.2% event move for LFST, spanning a range between $12.66 and $14.62.

Direct Sub-Reports: LFST RQD Cockpit LFST 12M Forecast LFST Earnings & Move LFST Dividends & DRIP LFST Insiders & 13F LFST Whale Options LFST Profit Sankey LFST News & Why